Log in
Enquire now
‌

US Patent 10047158 Anti-TIGIT antibodies and methods of use

Patent 10047158 was granted and assigned to Genentech on August, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Genentech
Genentech
0
Current Assignee
Genentech
Genentech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100471580
Patent Inventor Names
Yan Wu0
Dhaya Seshasayee0
Jane L. Grogan0
Mahesh Yadav0
Meredith Hazen0
Patrick Lupardus0
Robert J. Johnston0
Wei-Ching Liang0
Date of Patent
August 14, 2018
0
Patent Application Number
158957410
Date Filed
February 13, 2018
0
Patent Citations Received
‌
US Patent 11401339 Anti-TIGIT antibodies
‌
US Patent 11230596 Methods for treatment of cancer comprising TIGIT-binding agents
‌
US Patent 11667709 Anti-TIGIT antibodies and methods of use
0
‌
US Patent 11390678 Compositions and methods for the treatment of immune related diseases
Patent Primary Examiner
‌
Lei Yao
0
Patent abstract

The invention provides anti-TIGIT (T-cell immunoreceptor with Ig and ITIM domains) antibodies and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10047158 Anti-TIGIT antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.